Estimado (a) Dr. (a) le invitamos a ver el siguiente vídeo: “Obesidad como enfermedad Crónica”
Por la Dra. Tania Nava Ponce . Especialista en Medicina Interna y Obesidad. Adscrita al Centro Médico ABC en Clínica de nutrición y obesidad.
Referencias:
1 Marie Ng. Et al. The Lancet, May 29,2014
2 Obesity missing the 2005 global targets
3 WHO Factsheet 311. 2014 https//www.who.intl/
4 ABCDs of obesity, Endocr Pract. 2017;23
5 Sharma, Kusher Int J Obes (Lond) 2009; 33:289-95
6 American Medical Association Resolution: 420 (A-13). Available at: https//www.npr.org/documents/2013/jun/ama-resolution-obesity.pdf.
7 Rethink Obesity https://www.rethinkobesity.com/more-resources/educational-downloads.html
8 Charon R. JAMA. 2001;286:1897-1902;Laine C et al. JAMA. 1996;275:152-156
9 Norman G. N Engl J Med. 2006;355L2251-2252
10 Maldonado A et al. Patient Educ Couns. 2010;79:287-290
11 Kushner RF. American Medical Association, 2003. Kushner RF et al. American Diabetic Assosiation, 2009. Kushner RF et al. JAMA. 2014:312(9):943-952
12 Badman, Flier. Science 2005;307:1909-14;2. US Department of Health and Human Services, 1998. NIH Publication No. 98-4083
13 Badman et al. Science 2005;307:1909-14; Seo et al. Endocr J 2008;55:867-74
14 Secher et al. J Clin Invest 2014;124:4473-88
15 Boyle et al. Mol Metab 2018;8:203-10
16 Leibe et al. N Engl J Med 1995;332:621-8
17 Doucet et al. Int J Obes Relat Metab Disord 2000;24:906-14
18 Blomain et al. ISRN Obes 2013;2013:210524
19 Thomas et al. Am J Prev Med 2014; 46:17-23 5
20 Hill et al. Circulation 2012;126:126-32
21 Pasman et al. Obes Res 1999;7:43-50
22 Schwartz et al. Obes Rev 2010;11:531-47
23 Mann et al. Am Psychol 2007;62:220-33
24 Knowler WC et al. N Engl J Med. 2002;346(6):393-403
25 Wing RR et al. Diabetes Care. 2011;34(7):1481-1486
26 Riddle DL, Straford PW. Body weight changes and corresponding changes in pain and function in persons with symptomatic knee osteoarthritis: a cohort study. Arthritis Care Res (Hoboken).2013;65(1):15-22
27 Tuomilehto H et al. Sleep Med. 2014:15(3):329-335
28 Foster GD et al. Arch Intern Med. 2009;169(17):1619-1626
29 Warkentin LM, Das D, Majumdar SR, Johnson JA, Padwal RS. The effect of weight los on health-related quality of life: systematic review and meta-analysis of randomized trials. Obes Rev. 2014;15(3):169-182
30 Garber et al. Endocrine Practice: April 2015, vol. 21. No 4, pp. 438-447
31 Patel D. Metabolism 2015;64:1376-85
32 James et al. Lancet 2000;356:2119-25
33 BW, body weight; EOT, end of treatmen; FPG, fasting plasma glucose; FU, follow-up; LCD, low-calorie diet WL, weight loss Wadden et al. Int J Obes (Lond) 2013,37:1443-51
34 Lundgren JR et al. N Engl J Med 2021;384:1719-1730
Material desarrollado con fines de educación médica continua.
Material exclusivo para profesionales de la salud.
La información aquí presentada es opinión del ponente.
Código interno de aprobación: MX21SX00195
Por la Dra. Tania Nava Ponce . Especialista en Medicina Interna y Obesidad. Adscrita al Centro Médico ABC en Clínica de nutrición y obesidad.
Referencias:
1 Marie Ng. Et al. The Lancet, May 29,2014
2 Obesity missing the 2005 global targets
3 WHO Factsheet 311. 2014 https//www.who.intl/
4 ABCDs of obesity, Endocr Pract. 2017;23
5 Sharma, Kusher Int J Obes (Lond) 2009; 33:289-95
6 American Medical Association Resolution: 420 (A-13). Available at: https//www.npr.org/documents/2013/jun/ama-resolution-obesity.pdf.
7 Rethink Obesity https://www.rethinkobesity.com/more-resources/educational-downloads.html
8 Charon R. JAMA. 2001;286:1897-1902;Laine C et al. JAMA. 1996;275:152-156
9 Norman G. N Engl J Med. 2006;355L2251-2252
10 Maldonado A et al. Patient Educ Couns. 2010;79:287-290
11 Kushner RF. American Medical Association, 2003. Kushner RF et al. American Diabetic Assosiation, 2009. Kushner RF et al. JAMA. 2014:312(9):943-952
12 Badman, Flier. Science 2005;307:1909-14;2. US Department of Health and Human Services, 1998. NIH Publication No. 98-4083
13 Badman et al. Science 2005;307:1909-14; Seo et al. Endocr J 2008;55:867-74
14 Secher et al. J Clin Invest 2014;124:4473-88
15 Boyle et al. Mol Metab 2018;8:203-10
16 Leibe et al. N Engl J Med 1995;332:621-8
17 Doucet et al. Int J Obes Relat Metab Disord 2000;24:906-14
18 Blomain et al. ISRN Obes 2013;2013:210524
19 Thomas et al. Am J Prev Med 2014; 46:17-23 5
20 Hill et al. Circulation 2012;126:126-32
21 Pasman et al. Obes Res 1999;7:43-50
22 Schwartz et al. Obes Rev 2010;11:531-47
23 Mann et al. Am Psychol 2007;62:220-33
24 Knowler WC et al. N Engl J Med. 2002;346(6):393-403
25 Wing RR et al. Diabetes Care. 2011;34(7):1481-1486
26 Riddle DL, Straford PW. Body weight changes and corresponding changes in pain and function in persons with symptomatic knee osteoarthritis: a cohort study. Arthritis Care Res (Hoboken).2013;65(1):15-22
27 Tuomilehto H et al. Sleep Med. 2014:15(3):329-335
28 Foster GD et al. Arch Intern Med. 2009;169(17):1619-1626
29 Warkentin LM, Das D, Majumdar SR, Johnson JA, Padwal RS. The effect of weight los on health-related quality of life: systematic review and meta-analysis of randomized trials. Obes Rev. 2014;15(3):169-182
30 Garber et al. Endocrine Practice: April 2015, vol. 21. No 4, pp. 438-447
31 Patel D. Metabolism 2015;64:1376-85
32 James et al. Lancet 2000;356:2119-25
33 BW, body weight; EOT, end of treatmen; FPG, fasting plasma glucose; FU, follow-up; LCD, low-calorie diet WL, weight loss Wadden et al. Int J Obes (Lond) 2013,37:1443-51
34 Lundgren JR et al. N Engl J Med 2021;384:1719-1730
Material desarrollado con fines de educación médica continua.
Material exclusivo para profesionales de la salud.
La información aquí presentada es opinión del ponente.
Código interno de aprobación: MX21SX00195
EXELENTE PONECIA DRA
UNA PERDIDA DE PESO DEL 5% Y 10% PUDEN MEJORAR LAS COMORBILIDADES RELACIONADAS CON LA OBEIDAS
ELEXENTE TRATAMIENTO CON LA LIRAGLUTIDA 3.0MG
ES IMPORTANTE DND TRABAJA EL SITIOI DE ACCION LA LIRAGLUTIDA, YA QUE ACTUA A NIVEL DE GLP1
Excelente ponencia